Plegridy Injection, Solution
NDC Package 64406-017-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Plegridy (peginterferon beta-1a) injection is a medication used to treat multiple sclerosis (MS). This formulation utilizes a injection, solution delivery system. Marketed by Biogen Inc., this product is identified by NDC 64406-017 and is authorized under FDA application BLA125499.

Identification & Billing

NDC Package Code
64406-017-01
Package Description
1 TRAY in 1 CARTON / 2 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE (64406-017-02)
Product Code
64406-017
11-Digit Billing Format
64406001701
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1546172 - peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe
  • RxCUI: 1546172 - 0.5 ML peginterferon beta-1a 0.188 MG/ML Prefilled Syringe
  • RxCUI: 1546172 - peginterferon beta-1a 94 MCG per 0.5 ML Prefilled Syringe
  • RxCUI: 1546177 - Plegridy 94 MCG in 0.5 ML Prefilled Syringe
  • RxCUI: 1546177 - 0.5 ML peginterferon beta-1a 0.188 MG/ML Prefilled Syringe [Plegridy]

Clinical Specifications

Proprietary Name
Plegridy
Non-Proprietary Name
Peginterferon Beta-1a
Substance Name
Peginterferon Beta-1a
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
PEGINTERFERON BETA-1A 125 ug/.5mL
Pharmacologic Class
Usage Information
This medication is used to treat multiple sclerosis (MS). Peginterferon is not a cure for MS, but it may help to decrease the number of episodes of disease worsening (relapses) and slow the worsening of the disease.

Regulatory & Marketing

Labeler Name
Biogen Inc.
Product Type
Human Prescription Drug
FDA Application #
BLA125499
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
01-29-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64406-017-01 identifies a specific commercial package of 1 tray in 1 carton / 2 syringe in 1 tray / .5 ml in 1 syringe (64406-017-02) of Plegridy, a human prescription drug labeled by Biogen Inc.. This injection, solution is formulated for intramuscular use and contains peginterferon beta-1a as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biogen Inc. on January 29, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat multiple sclerosis (MS). Peginterferon is not a cure for MS, but it may help to decrease the number of episodes of disease worsening (relapses) and slow the worsening of the disease.

How is this Biogen Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64406001701. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64406-017-01
11-Digit CMS (5-4-2)
64406-0017-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.